Summary:
A phase3, multicenter, single-arm, open-label, study to evaluate the safety, pharmacokinetics and effectiveness of intravenous peramivir in elderly subjects, (65 years old or older) with acute uncomplicted influenza infection.
Qualified Participants Must:
• Have current Flu symptoms one or more of these symptoms:
- cough
- body ache and pains
- fever, fatigue
- headache
- sore throat
- nasal congestion
• Age 65 or older
• Onset of Flu symptoms within 48 hours
Qualified Participants May Receive:
Study medication that could make you feel better, faster; study exams; compentsation for time and travel: transportation could be provided.